
Do All Chemotherapies Have Equal Long-Term Heart Risk?
In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs with development of cardiomyopathy (abnormal heart muscle with impaired function) years after treatment. “Exposure to anthracycline chemotherapies, such as doxorubicin, has long…